Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020).

Article  CAS  PubMed  Google Scholar 

Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403–416 (2020).

Article  PubMed  Google Scholar 

Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379, 11–21 (2018).

Article  CAS  PubMed  Google Scholar 

Gillmore, J. D. et al. CRISPR–Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493–502 (2021).

Article  CAS  PubMed  Google Scholar 

Verve Therapeutics doses first human with an investigational in vivo base editing medicine, VERVE-101, as a potential treatment for heterozygous familial hypercholesterolemia. Verve Therapeutics https://ir.vervetx.com/news-releases/news-release-details/verve-therapeutics-doses-first-human-investigational-vivo-base (2022).

Longhurst, H. J. et al. CRISPR–Cas9 in vivo gene editing of KLKB1 for hereditary angioedema. N. Engl. J. Med. 390, 432–441 (2024).

Article  CAS  PubMed  Google Scholar 

Ferrari, G., Thrasher, A. J. & Aiuti, A. Gene therapy using haematopoietic stem and progenitor cells. Nat. Rev. Genet. 22, 216–234 (2021).

Article  CAS  PubMed  Google Scholar 

Salinas Cisneros, G. & Thein, S. L. Recent advances in the treatment of sickle cell disease. Front. Physiol. 11, 435 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Taher, A. T., Musallam, K. M. & Cappellini, M. D. β-thalassemias. N. Engl. J. Med. 384, 727–743 (2021).

Article  PubMed  Google Scholar 

Cazzola, M. Introduction to a review series on inherited anemias. Blood 136, 1215–1216 (2020).

Article  CAS  PubMed  Google Scholar 

Castagnoli, R., Delmonte, O. M., Calzoni, E. & Notarangelo, L. D. Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives. Front. Pediatr. 7, 295 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Tan, E. Y., Boelens, J. J., Jones, S. A. & Wynn, R. F. Hematopoietic stem cell transplantation in inborn errors of metabolism. Front. Pediatr. 7, 433 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Eichler, F. et al. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N. Engl. J. Med. 377, 1630–1638 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frangoul, H. et al. CRISPR–Cas9 gene editing for sickle cell disease and β-thalassemia. N. Engl. J. Med. 384, 252–260 (2021).

Article  CAS  PubMed  Google Scholar 

Locatelli, F. et al. Betibeglogene autotemcel gene therapy for non-β0/β0 genotype β-thalassemia. N. Engl. J. Med. 386, 415–427 (2021).

Article  PubMed  Google Scholar 

Kanter, J. et al. Biologic and clinical efficacy of LentiGlobin for sickle cell disease. N. Engl. J. Med. 386, 617–628 (2022).

Article  CAS  PubMed  Google Scholar 

Domingues, M. J., Nilsson, S. K. & Cao, B. New agents in HSC mobilization. Int. J. Hematol. 105, 141–152 (2017).

Article  CAS  PubMed  Google Scholar 

Atilla, E., Ataca Atilla, P. & Demirer, T. A review of myeloablative vs reduced intensity/non-myeloablative regimens in allogeneic hematopoietic stem cell transplantations. Balkan Med. J. 34, 1–9 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Shi, D., Toyonaga, S. & Anderson, D. G. In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles. Nano Lett. 23, 2938–2944 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Breda, L. et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science 381, 436–443 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Breda, L. et al. In vivo modification of hematopoietic stem cells by targeted lipid nanoparticles encapsulating mRNA. Blood 140, 305–306 (2022).

Article  Google Scholar 

Li, C. et al. Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors. Mol. Ther. Methods Clin. Dev. 24, 127–141 (2022).

Article  PubMed  Google Scholar 

Mui, B. L. et al. Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles. Mol. Ther. Nucleic Acids 2, e139 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eygeris, Y., Patel, S., Jozic, A. & Sahay, G. Deconvoluting lipid nanoparticle structure for messenger RNA delivery. Nano Lett. 20, 4543–4549 (2020).

Article  CAS  PubMed  Google Scholar 

Kulkarni, J. A., Witzigmann, D., Leung, J., Tam, Y. Y. C. & Cullis, P. R. On the role of helper lipids in lipid nanoparticle formulations of siRNA. Nanoscale 11, 21733–21739 (2019).

Article  CAS  PubMed  Google Scholar 

Kauffman, K. J. et al. Rapid, single-cell analysis and discovery of vectored mRNA transfection in vivo with a loxP-flanked tdTomato reporter mouse. Mol. Ther. Nucleic Acids 10, 55–63 (2018).

Article  CAS  PubMed  Google Scholar 

Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing. Nat. Nanotechnol. 15, 313–320 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

LoPresti, S. T., Arral, M. L., Chaudhary, N. & Whitehead, K. A. The replacement of helper lipids with charged alternatives in lipid nanoparticles facilities targeted mRNA delivery to the spleen and lungs. J. Control. Release 345, 819–831 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Radmand, A. et al. The transcriptional response to lung-targeting lipid nanoparticles in vivo. Nano Lett. 23, 993–1002 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paunovska, K. et al. A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation. Nano Lett. 18, 2148–2157 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dobrowolski, C. et al. Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery. Nat. Nanotechnol. 17, 871–879 (2022).

Article  CAS  PubMed  Google Scholar 

Tiwari, P. M. et al. Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection. Nat. Commun. 9, 3999 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Hatit, M. Z. C. et al. Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles. Nat. Nanotechnol. 17, 310–318 (2022).